학술논문

Anticancer Effect of Rh2, a Histone Deacetylase Inhibitor, in HepG2 Cells and HepG2 Cell-Derived Xenograft Tumors Cccurs via the Inhibition of HDACs and Activation of the MAPK Signaling Pathway
Document Type
Article
Source
In: Asian Pacific Journal of Cancer Prevention. (Asian Pacific Journal of Cancer Prevention, August 2021, 22(8):2529-2539)
Subject
Language
English
ISSN
2476762X
15137368